Pharmaceutical companies to shun direct transaction with pharmacy

Published: 2010-12-22 06:58:00

Updated: 2010-12-22 06:58:00

Influenced by the government’s anti-rebate policy, a number of pharmaceutical firms are moving forward to hospital markets, while shunning away from pharmacy market.

What has turned pharmaceutical companies around? The changes in the domestic pharmaceutical industry are the main cause to blame...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK